Avalo Therapeutics (AVTX) Other Non Operating Income (2020 - 2025)
Avalo Therapeutics (AVTX) posted Other Non Operating Income of -$3000.0 for Q3 2025, up 40.0% on a QoQ basis from -$5000.0 in Q2 2025, and up 40.0% year-over-year from -$2142.9 in Q3 2024.
Avalo Therapeutics (AVTX) Other Non Operating Income (2020 - 2025) Analysis & Trends
Avalo Therapeutics' Other Non Operating Income history runs 5 years deep, the most recent figure standing at -$3000.0 for Q3 2025.
- Quarterly Other Non Operating Income rose 40.0% year-over-year to -$3000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$13000.0 (up 89.6% YoY) and the FY2024 annual result came in at -$5000.0, up 88.1% from the prior year.
- Other Non Operating Income was -$3000.0 for Q3 2025 at Avalo Therapeutics, up from -$5000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at -$3000.0 in Q3 2025 and bottomed at -$180000.0 in Q1 2023.
- A 4-year average of -$43750.0 and a median of -$10000.0 in 2021 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2021 — Other Non Operating Income sank 178.95% — and 2024, when it jumped 70.59%.
- Avalo Therapeutics' Other Non Operating Income stood at -$15000.0 in 2021, then retreated by 13.33% to -$17000.0 in 2023, then jumped by 70.59% to -$5000.0 in 2024, then soared by 40.0% to -$3000.0 in 2025.
- Business Quant data shows AVTX's Other Non Operating Income at -$3000.0 in Q3 2025, -$5000.0 in Q2 2025, and -$5000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Avalo Therapeutics | 395.30 Mn | 338.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -5,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -120,000.00 |
| Sep 30, 2023 | -17,000.00 |
| Mar 31, 2023 | -180,000.00 |
| Sep 30, 2021 | -15,000.00 |
| Jun 30, 2021 | -5,000.00 |
| Dec 31, 2020 | -38,000.00 |
| Sep 30, 2020 | 19,000.00 |
| Jun 30, 2020 | 398,000.00 |
| Mar 31, 2020 | 11,000.00 |